Biogipuzkoa
Centro de investigación
University of California Los Angeles
Los Ángeles, Estados UnidosPublicaciones en colaboración con investigadores/as de University of California Los Angeles (15)
2024
-
Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches
Journal of Extracellular Vesicles, Vol. 13, Núm. 2
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Current management of xerostomia in head and neck cancer patients
American Journal of Otolaryngology - Head and Neck Medicine and Surgery, Vol. 44, Núm. 4
-
Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)
Nature
2022
-
Temporal order of clinical and biomarker changes in familial frontotemporal dementia
Nature medicine, Vol. 28, Núm. 10, pp. 2194-2206
-
The ENIGMA Stroke Recovery Working Group: Big data neuroimaging to study brain–behavior relationships after stroke
Human Brain Mapping, Vol. 43, Núm. 1, pp. 129-148
2021
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
Mapping the human genetic architecture of COVID-19
Nature, Vol. 600, Núm. 7889, pp. 472-477
2019
-
A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity
Acta Neuropathologica, Vol. 138, Núm. 2, pp. 237-250
2018
-
Mutations in multiple components of the nuclear pore complex cause nephrotic syndrome
Journal of Clinical Investigation, Vol. 128, Núm. 10, pp. 4313-4328
-
Personal exposure to radio-frequency electromagnetic fields in Europe: Is there a generation gap?
Environment International, Vol. 121, pp. 216-226
-
Spatial and temporal variability of personal environmental exposure to radio frequency electromagnetic fields in children in Europe
Environment International, Vol. 117, pp. 204-214
2013
-
Neurodegenerative disease phenotypes in carriers of MAPT P.A152T, a risk factor for frontotemporal dementia spectrum disorders and alzheimer disease
Alzheimer Disease and Associated Disorders, Vol. 27, Núm. 4, pp. 302-309
2010
-
Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per μl in Europe and North America: A pooled cohort observational study
The Lancet, Vol. 376, Núm. 9738, pp. 340-345